Reagents


Lab Services
Homepage > services > Metabolism
Share on Facebook Share on Twitter Share on LinkedIn
 

Metabolism

Ou partner XenoTech has unparalleled experience and expertise in evaluating drug candidates as substrates, inhibitors and inducers of drug-metabolizing enzymes. They have a strong commitment to continuous systems improvement with the latest technologies, while ensuring the accuracy and reliability of the data generated.

To assess the victim and perpetrator potential of drug candidates, XenoTech conducts a variety of in vitro pre-clinical studies in accordance with the FDA's latest guidance (PDF).  They offer non-GLP studies as well as studies conducted in compliance with GLP regulations.

Although most of these studies are conducted on drug candidates, XenoTech has performed studies on other xenobiotics such as pesticides, cosmetics, fragrances, nutraceuticals and herbal preparations.

  • Drug-Metabolizing Enzyme (DME) Inhibition  
  • DME Induction
  • Reaction Phenotyping (Enzyme Mapping)
  • Species Comparison
  • Metabolic Stability
  • Metabolite Characterization and Identification
  • Toxicity in Primary Cultures of Human and Animal Hepatocytes

XenoTech scientists have delivered invited seminars, taught drug metabolism courses and consulted on metabolism-related issues for numerous organizations worldwide, including the FDA. They conduct studies following customized protocols, and have extensive experience in the preparation of customized reports for clients from all over the world. Non-GLP as well as GLP-compliant studies for FDA, EPA, MHLW and other submissions are offered.

 

Click here to contact us about your project
 
tebu-bio for you
Related Downloads